缺血型视网膜中央静脉阻塞的光凝治疗

Observation on clinical effects of panretinal photocoagulation for ishchemic type of central retinal vein occlusion

关键词:  缺血型视网膜中央静脉阻塞  氩激光  视网膜光凝术

Key words:  ishchemic type of central retinal vein occlusion  Argon laser  retinal photocoagulation

摘要:

［目的］ 观察氩激光视网膜光凝（Panrentinal photocoagulation, PRP）治疗缺血型视网膜中央静脉阻塞的临床疗效。［方法］ 根据眼底荧光血管造影（FFA）结果，对确诊为缺血型视网膜中央静脉阻塞的46例46眼进行氩激光视网膜光凝治疗，光凝后每2周复查眼底，每3个月复查FFA，并随诊观察6个月～2年。［结果］ 本组46眼经视网膜光凝后39眼有效，总有效率为84.8％，光凝治疗后视力提高7眼，占15.2％；33眼视力不变，占71.7％，视力下降6眼，占13.1％。［结论］ 氩激光视网膜光凝术治疗治疗缺血型视网膜静脉阻塞是安全、有效的。

Abstract:

［Objective］Observing and evaluating the clinical effects of panretinal photocoagulation with Argon laser for ishchemic type of central retinal vein occlusion.［Methods］ According to the results of fundus fluorescence angiography (FFA), panretinal photocoagulation with Argon laser were performed on 46 eyes (46 cases)of ishchemic type of central retinal vein occlusion.After photocoagulation, examination about fundus condition were carried out every 3 months, FFA was performed every two weeks. The vegular following up lasted for 6 months to 2 years.［Results］ Laser photocoagulation was proved effective in 39 eyes (84.8%) with ishchemic type of central retinal vein occlusion.The visual acuity was improved in7 eyes (15.2%),no changes in 33 eyes (71.7%), decrease in 6 eyes (13.1%).［Conclusion］ Panretinal hotocoagulation with Argon laser is a safe and effective method to treat ishchemic type of central retinal vein occlusion.